The effects of naproxen and sulindac on renal function and their interaction with hydrochlorothiazide and piretanide in man.
We have studied the effect of a single dose challenge of naproxen (500 mg) and sulindac (200 mg) on renal function in five volunteers, and the effect of a single dose challenge of the thiazide, hydrochlorothiazide (100 mg), and loop diuretic, piretanide (6 mg) on renal function when the diuretics were given alone or when superimposed on chronic therapy of either naproxen or sulindac. None of the nonsteroidal anti-inflammatory drug (NSAID) or diuretic exposures significantly influenced glomerular filtration rate, as measured by creatinine clearance. Over the first 4 h of the study, both naproxen and sulindac reduced fractional excretion of sodium by approximately 50%. Sulindac also caused a significant uricosuria whilst naproxen promoted urate retention. Similar changes were observed over 8 h. Superimposition of either hydrochlorothiazide or piretanide on top of chronic sulindac therapy resulted in a blunting of the natriuresis by approximately 30% compared to when these diuretics were given alone: the action of the diuretics was unchanged by naproxen. Sulindac pretreatment did not alter the urinary excretion of either hydrochlorothiazide or piretanide; naproxen did not alter hydrochlorothiazide excretion. On the basis of these findings, it is concluded that NSAIDs exert direct tubular effects that do not necessarily interfere with the delivery of diuretics to their sites of action within the nephron.
D000328:Adult; D004231:Diuresis / Q000187:drug effects; D004347:Drug Interactions; D006801:Humans; D006852:Hydrochlorothiazide / Q000494:pharmacology*; D007192:Indenes / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects*; D008297:Male; D009288:Naproxen / Q000494:pharmacology*; D009318:Natriuresis / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology*; D013467:Sulindac / Q000494:pharmacology*
D007192:Indenes; D013449:Sulfonamides; D006852:Hydrochlorothiazide; D013467:Sulindac; D009288:Naproxen; C015451:piretanide